TCL Archive In Brief: Charles Smart To Give Up Commission On Cancer Post, Kansas Surgeon To Become Fulltime Director April 15, 1983
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says April 26, 1996